Identity
- Security key
- 20366
- Ticker
- PRPO
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2000-07-18
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- PRPO
Detail
Enriched 2026-08-14 20:47
- Market cap
- $40,287,364.88
- Shares outstanding (class)
- 1,787,372
- Shares outstanding (weighted)
- 1,787,372
- SIC
- 3826 LABORATORY ANALYTICAL INSTRUMENTS
- Employees
- 71
- Location
- NEW HAVEN, CT
- Homepage
- https://www.precipiodx.com
- Description
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.